Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Nov;84(11):1145-9.
doi: 10.1111/j.1349-7006.1993.tb02814.x.

Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta

Affiliations

Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-beta

X Li et al. Jpn J Cancer Res. 1993 Nov.

Abstract

We have studied the effects of growth factors and cytokines on the tumorigenicity and invasion capacity of tumor cells by using regressor and progressor tumor cell lines (ER-1 and ERpP, respectively) derived from an SHR rat mammary adenocarcinoma. ER-1 cells regress spontaneously whereas ERpP cells show invasive growth and high metastasis to lung and other organs in syngeneic SHR rats. When ER-1 cells were pretreated with either epidermal growth factor (EGF) or transforming growth factor-beta (TGF-beta) for 24 h in vitro, and intraperitoneally transplanted into SHR rats, they grew and killed the host, whereas ER-1 cells pretreated with tumor necrosis factor-alpha did not. Tumorigenicity and invasion capacity of ERpP cells were also enhanced by treatment with EGF and TGF-beta. The ER-1 cells pretreated with EGF, once grown in vivo, had acquired irreversible tumorigenicity and invasion capacity without requiring further EGF treatment, and the enhanced malignancy was irreversible. These findings suggest that growth factors play an important role in acquisition of malignancy of tumor cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. ) Nowell , P. C.Mechanisms of tumor progression . Cancer Res. , 46 , 2203 – 2207 ( 1986. ). - PubMed
    1. ) Wei , W. and Heppner , G. H.Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors . Cancer Immunol. Immunother. , 26 , 257 – 262 ( 1988. ). - PMC - PubMed
    1. ) Rice , G. E. , Gimbrone , M. A. and Bevilacqua , M. P.Tumor cell‐endothelial interaction . Am. J. Pathol. , 133 , 204 – 211 ( 1988. ). - PMC - PubMed
    1. ) Breillout , F. , Antoine , E. , Lascaux , V. , Rolland , Y. and Poupon , M. F.Promotion of micrometastasis proliferation in a rat rhabdomyosarcoma model by epidermal growth factor . J. Natl. Cancer Inst. , 81 , 702 – 705 ( 1989. ). - PubMed
    1. ) Mukai , M. , Shinkai , K. , Komatsu , K. and Akedo , H.Potentiation of invasive capacity of rat ascites hepatoma cells by transforming growth factor‐β . Jpn. J. Cancer Res. , 80 , 107 – 110 ( 1989. ). - PMC - PubMed

Publication types

Substances

LinkOut - more resources